Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Urethral dilation is a procedure for the initial treatment of urethral stricture diseases. The increasing use of urethral dilators to treat prostate cancer, kidney stones and obesity is driving the demand for urethral dilator products. These products help reduce major surgeries by allowing easy placement and removal of stents and catheters.
The demand for urethral dilators is increasing due to the high prevalence of chronic kidney disease, the increase in urinary stones and urinary tract infections, and the rapidly growing baby boomer population. Urethral dilators are often used to treat urethral strictures, which mean a narrowing of the urethra making it difficult to pass urine. This condition accounts for nearly 1.5 million office visits per year in the United States. This is done by inserting a thin rod into the urethra to widen the urethral passage. In some cases, dilation may be required before large instruments such as a resectoscope are inserted into the urethra. Additionally, people suffering from fibrosis, inflammation, trauma, and birth defects use urethral dilators to dilate the urinary tract. Additionally, surgical infections, the risk of recurrence, and the ease of dilation at home is anticipated to drive the industry's growth over the next few years.
The rising incidence of urethral strictures, prostate cancer, injuries, kidney stones and medical conditions requiring urethral dilators are expected to lead the market over the forecast period. According to data published by Laborie Medical Technologies Inc. (Laborie), a leader in diagnostics and therapy in medical technology, urethral stricture is a common disease in men, with an incidence of approximately 1 in 10,000 within 25 years of age and approximately 1 in 1,000 men aged 65 and over. In addition, according to the study published in the National Center for Biotechnology Information (NCBI), in 2018 it is estimated that 12% of the Indian population suffers from urolithiasis, 50% of which could end up with loss of kidney function and urethral obstructions. Likewise, an estimated 600,000 people in the United States suffer from urinary stones each year, which equates to 1 in 11 people who suffer from kidney stones. All the factors mentioned above are likely to drive the growth of the market over the forecast period.
In addition, the market is expected to be driven by a large geriatric population, which highly susceptible to various diseases, including kidney and urinary tract disorders. According to the WHO, the global population aged 65 and over is projected to increase from 7% in 2000 to 16% in 2050. Old age is considered one of the major risk factors for developing various medical conditions. Aging also weakens the immune system and consequently increases the patient's susceptibility to various conditions such as kidney disease, diabetes, prostate cancer, and urinary retention. As a result, all of these conditions can lead to thinning of the urethra, which can lead to problems with urination. This is done by inserting a thin rod (urethral dilators) into the urethra, resulting in an enlargement of the urethral passage. The increase in the geriatric population is therefore one of the main drivers for the market.
The market is expected to have new opportunities with the technological advancements and ongoing R&D activities involved in manufacturing urethral dilators is expected to provide ample of new growth opportunities in the market during the forecast period. Also, minimally invasive surgeries are becoming increasingly popular among patients and doctors, driving the growth of the urethral dilators market. The advent of these minimally invasive techniques to treat urological diseases and conditions related to the kidneys, prostate and bladder are also fuelling the demand in the Urethral Dilators market. Besides, urethral dilators with emerging features has gained major attention of healthcare professionals and this factor is expected to provide rising new growth opportunities for the market over the forecast period.
There are certain side effects which may occur due to the use of urethral dilators. Some of these side effects are infection, harm to the urethra, blood clots, stroke etc. Besides, the lack of an advanced healthcare infrastructure in underdeveloped nations is another factor is expected to restrain market growth over the forecast period.
The high cost of urethral dilators is a key element that may affect the growth of the market. Also, a lack of skilled healthcare workers is expected to be a major hinderance to market growth over the forecast period.
The report provides an in-depth analysis of the global Urethral Dilators market, market size, and compound annual growth rate (CAGR) for the forecast period of 2023-2029, considering 2022 as the base year. With increasing demand for urethral dilators in various applications has led the increasing demand for market and is expected to witness growth at a specific CAGR from 2022-2029.
The global Urethral Dilators market comprises of different market segment like type, usage, application, end users and geography.
By type, the Urethral Dilators market includes the key segments of
Hydraulic urethra dilator segment is expected to dominate the market over the forecast period. Specially armoured balloons and precise manufacturing allow for patient-safe dilation of the urethra with minimal procedural risks during treatment. Therefore, new product offerings and launches from key suppliers will drive the segment's growth.
On the other side, other urethral dilators like bougie dilators are available. It may be used to treat strictures and blockages in the oesophagus, the intestines, the rectum, the anus, the ureters (the tubes that transport urine from the kidneys to the bladder) and the urethra (the canal that transports urine from the bladder to the outside).
By usage, the Urethral Dilators market is segmented into
Disposable segment is expected to maintain its dominance over the estimated time period. Disposable urethral dilators are single use and are considered a cost effective alternative to reusable ones. In terms of safety and quality, they are preferred to reusable ones. Additionally, these can help reduce the risk of contamination and transmission of infection from one patient to another. All of these benefits is expected to drive the segment's growth over the forecast period.
Also, in the case of reusable dilators, proper cleaning and disinfection according to FDA guidelines are very necessary to prevent the transmission of any infection from one patient to another. The risk of infection transmission is comparatively lower than with disposable urethral dilators, which is why healthcare professionals generally prefer disposable urethral dilators. Moreover, the presence of numerous key players offering disposable urethral dilators is expected to propel the segment during the forecast period. Thus, all the above-mentioned factors is expected to contribute to the growth of the segment.
The Urethral Dilators market has key applications in
The urethral strictures segment is expected to find increasing demand in the market over the forecast period due to the increase in cases of urinary tract infections, progress in the development of therapeutics to treat urinary tract strictures , public-private partnerships to raise awareness and the increasing penetration of large companies in emerging markets. Urethral strictures are usually the result of inflammation and injury caused by repetitive medical procedures such as catheters or surgery, or infection, which can cause scarring/strictures in or around the urethra and block the flow of urine. Associated risk factors are urinary tract infections, thickening of the walls, hydronephrosis and the formation of bladder stones. This is expected to drive the growth of the segment over the forecast period.
The kidney stone removal segment is expected to grow at the fastest rate over the forecast period. The increasing adoption of minimally invasive procedures and risk factors that cause kidney stones, such as diabetes, obesity and kidney dysfunction, are major contributors to segment growth.
Furthermore, the ease of use, non-invasive nature, cost-effectiveness and high efficacy in treating stones are the advantages of using dilators during the process. Additionally, these procedures can be performed on an outpatient basis due to the shorter delivery times. All of these benefits are anticipated to drive demand over the forecast period.
The Urethral Dilators market has major end users like
The hospital segment is expected to dominate the market due to an increase in the number of patients with various urological diseases, which has led to an increase in surgical treatments. Additionally, hospitals see a much higher influx of patients for urological procedures or other treatments than other healthcare facilities due to the ease of handling emergencies that may arise during surgical procedures and the wide range of medical procedures that are available. As a result, the hospitals segment is likely to be driven by the aforementioned variables.
The home care settings segment is expected to expand at the fastest CAGR over the estimated time period. The patient-friendliness, cost-effectiveness, and safety associated with these devices are contributing to their growing popularity at home. In addition, rising hospital costs make home care a better option, especially for the elderly population. A number of urethral or meatal dilators have been used to perform self-dilation at home or in privacy to keep the urethral passage open and prevent recurrence of a urethral stricture or other urethral obstruction. Thus, the advances and availability of urethral dilators for home use are increasing the demand for urethral dilators in home care settings.
The global Urethral Dilators market is studied for the following region
North America is expected to dominate the market over the forecast period. The growth in the region is primarily driven by the growing incidence of targeted diseases, such as bladder obstruction, user interface, benign prostatic hyperplasia (BPH), urinary retention and bladder cancer. For example, according to the American Academy of Family Physicians (AAFP), more than 250,000 patients with BPH undergo surgical procedures every year. This condition can occur due to aging or trauma / injury to the penis, urethra or bladder and is also associated with pregnancy. Furthermore, the high purchasing power of consumers and the increased adoption of advanced technologies and innovative medical devices should lead the market.
Asia-Pacific is expected to register the highest CAGR during the forecast period. This can be attributed to the presence of a large population suffering from kidney and other urological diseases, the improvement of medical facilities and the availability of insurance policies. In addition, the presence of a large patient pool and the growing need for technologically advanced and cost-effective healthcare solutions are expected to provide significant regional growth opportunities.
The exclusive COVID-19 impact analysis report by Axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the global Urethral Dilators market. In addition, complete analysis of changes on the global Urethral Dilators market expenditure, economic and international policies on supply and demand side. The report also studies the impact of the pandemic on global economies, international trade, business investments, GDP and marketing strategies of key players present in the market.
The COVID-19 pandemic is expected to have a moderate impact on market growth. All urological surgeries were considered non-urgent during the pandemic. For this reason, all outpatient and elective interventional procedures to reduce risk were reduced or suspended. According to the African Journal of Urology in 2022, all types of elective urological procedures have decreased significantly. In particular, ureteroscopic lithotripsy, percutaneous nephrolithotomy, transurethral resection of the prostate, urethroplasty, and kidney transplantation had the highest reduction. However, as lockdown restrictions are lifted in most countries, the supply chains of most healthcare companies are expected to operate efficiently and smoothly over the forecast period. Hence, the global market is expected to grow significantly in the coming years.
The competitive landscape analysis of Urethral Dilators market is majorly focused on expanding the global growth of urethral dilators industry with new product innovation, business expansion, increasing presence of range of manufacturers operating in urethral dilators sector has led the growing demand for the market. Besides, the market offers range of products in different application to fulfil the required demand of consumer which is further contributing healthy growth in the market.
The key players studied in market are
June 2020: B. Braun Melsungen AG had launched virtual support services during the COVID-19 crisis to help weak patients at home with acute bladder problems. This service delivers continence and ostomy care products to patients at home by providing FaceTime video tutorials and advice on distribution channels.
February 2019: Coloplast had signed a three-year agreement with Premier Inc., a U.S.-based healthcare improvement company, for its urology products. The general urological products include drainage systems, dilators, catheters, and other accessories, thereby increasing penetration of the product in a new market.
By type, the Urethral Dilators market includes the key segments of hydraulic urethra dilator and others. Hydraulic urethra dilator segment is expected to dominate the market over the forecast period. By usage, the Urethral Dilators market is segmented into Disposable and Reusable. Disposable segment is expected to maintain its dominance over the estimated time period. The Urethral Dilators market has key applications in urethral stricture, meatal stenosis, kidney stone removal and others. The urethral stricture segment is expected to find increasing demand in the market over the forecast period. The Urethral Dilators market has major end users like hospitals, clinics, ambulatory surgical centers and home care settings. The hospital segment is expected to dominate the market due to an increase in the number of patients with various urological diseases, which has led to an increase in surgical treatments. The global Urethral Dilators market is studied for the following regions: North America, Europe, Asia-Pacific and Rest of the world (RoW). North America is expected to dominate the market over the forecast period.
| Market Sizing for Year: | 2019-2029 |
| Base Year: | 2022 |
| Forecast Period: | 2023-2029 |
| Value: | USD
million |
| Market Segment studied: | Type Usage Application End Users |
| Market Players and its Competitors: | Boston Scientific Corporation B. Braun Melsungen AG MED pro Medical BV BD Teleflex Inc. Cook Medical UROMED Kurt Drews KG. Urovision-Urotech Coloplast Smith’s Medical Ace Medical Devices Bard Medical Envaste Rontis Medical Zhejiang Chuangxiang Medical Technology |
FREQUENTLY ASKED QUESTIONS
What would be forecast period in the market report?
2023-2029 is the forecast period in the market report.
Which is the leading application segment for Urethral Dilators market?
Urethral stricture has accounted the major market share, and is expected to witness the growth at highest pace during the forecast period.
Which region is gaining majority of market share during the forecast period (2023-2029)?
North America is expected to gain major market share during the forecast period (2023-2029).
